Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

13 June 1997

Antibodies and chronic organ graft rejection

L C Paul

Ann Transplant 1997; 2(2): 46-52 :: ID: 497155

Abstract

The development of chronic rejection within weeks or months after transplantation in allogeneic organ transplan ts provides a compelling case in favour of the hypothesis that alloimmune reactions playa major pathogenetic role in this syndrome. Although most if not all of the lesions of chronic rejection can also emerge in syngeneic transplants [1,2], it usually takes a much longer time interval to develop in such grafts. In experimental animals, retransplantation of allogeneic kidney or heart transplants back into the original donor strain often prevents the development of chronic rejection if done within a certain time frame [3,4], suggesting that persistent alloimmune reactivity is required for the induction chronic rejection.

Keywords: chronic rejection, kidney transplants, heart transplants, anti bodies

Add Comment 0 Comments

In Press

Original article  

Learning Curve and Outcomes of Pure Laparoscopic Donor Major Hepatectomy Performed by Fellowship-Trained Su...

Ann Transplant In Press; DOI: 10.12659/AOT.953061  

Original article  

Role of Psychological Resilience on Emotional Health in Kidney and Liver Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.952824  

Original article  

Analysis of Factors Influencing the Psychological State of Patients After Autologous Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.953645  

Original article  

Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...

Ann Transplant In Press; DOI: 10.12659/AOT.953761  

Most Viewed Current Articles

24 Aug 2021 : Review article   21,725

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   17,946

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Nov 2022 : Original article   16,696

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

05 Apr 2022 : Original article   16,590

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358